Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01335750 · ClinicalTrials.gov registry record · NA
A Clinical Comparison of Marketed Lens Care Solutions With Avaira Lens Brand
A NA study, sponsored by CooperVision.
- Completed
- Registry status
- NA
- Development phase
- 32
- Enrollment target
NCT01335750: Completed NA study, sponsored by CooperVision.
NCT01335750 is a NA study that has completed, run by CooperVision. The registered enrollment target is 32 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01335750, a NA study, has completed, sponsored by CooperVision.
- COMPLETED
- Registry status
- NA
- Development phase
- 32 participants
- Enrollment target
Study Summary
This study is a clinical comparison of the biocompatibility of several multipurpose solutions, Renu Fresh, Optifree Replenish, and ClearCare, and saline as a control solution among adapted hydrogel contact lens wearers wearing Avaira (enfilcon A) contact lenses at one research site.
Primary Outcome
Severity of staining was recorded for each region using a scale of 0-none to 4-patch \>/=1mm. Analysis of staining was performed by averaging the scores from the five regions for each eye, then identifying the subject's worse eye at each visit. Mean total severity was calcuated from all identified eyes for each visit.
Interventions
- OTHER Multipurpose Solution #1
- OTHER Multipurpose Solution #2
- OTHER Mutlipurpose Solution #3
- OTHER Multipurpose Solution #4
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2010-08 |
| Est. Completion | 2010-09 |
| Phase | NA |
What the finished NCT01335750 record still lists
NCT01335750 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 32 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 4 interventions - of which Multipurpose Solution #1 is the first listed.
NCT01335750 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01335750 about?
NCT01335750 is a clinical study titled "A Clinical Comparison of Marketed Lens Care Solutions With Avaira Lens Brand". This study is a clinical comparison of the biocompatibility of several multipurpose solutions, Renu Fresh, Optifree Replenish, and ClearCare, and saline as a control solution among adapted hydrogel contact lens wearers wearing Avaira (enfilcon A) contact lenses at one research site.
What is the current status of trial NCT01335750?
This trial is currently completed. It is a NA study. The enrollment target is 32 participants. The study started on 2010-08. Estimated completion is 2010-09.
What interventions are being tested in trial NCT01335750?
The interventions under investigation include: Multipurpose Solution #1 (OTHER), Multipurpose Solution #2 (OTHER), Mutlipurpose Solution #3 (OTHER), Multipurpose Solution #4 (OTHER).
Who is sponsoring clinical trial NCT01335750?
This trial is sponsored by CooperVision, which has 64 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01335750's enrollment target sits among peer trials
32 1578th of 2000 higher than 409 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02445781 · 32 participants · Early Phase 1
Differing Levels of Hypoglycemia
- NCT02792270 · 32 participants · NA
Caloric Restriction In Sarcoma Patients Treated With Pre-Operative RT
- NCT03068910 · 32 participants · Early Phase 1
Hyperandrogenemia and Altered Day-night LH Pulse Patterns
- NCT03208868 · 32 participants · NA
Leucine Enriched Essential Amino Acid Mixture to Reverse Muscle Loss in Cirrhosis
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia